S. Ghantoji

发表

Economic healthcare costs of Clostridium difficile infection: a systematic review.

D R Lairson, K. Garey, H. Dupont, 2010, The Journal of hospital infection.

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation.

R. Champlin, R. Chemaly, C. Hosing, 2012, Blood.

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia

Daniel Patrick Smith, N. Ajami, J. Petrosino, 2016, Cancer.

Management of respiratory viral infections in hematopoietic cell transplant recipients.

R. Chemaly, S. Ghantoji, E. Ariza-Heredia, 2012, American journal of blood research.

Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms.

J. Stachowiak, R. Chemaly, I. Raad, 2015, Journal of medical microbiology.

Non-inferiority of pulsed xenon ultraviolet light versus bleach versus for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile isolation rooms.

Raad, J. Stachowiak, R. Chemaly, 2015 .

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

K. Garey, Maki Habib, H. Dupont, 2011, The Journal of antimicrobial chemotherapy.

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.

R. Champlin, R. Chemaly, L. Nesher, 2014, Blood.

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

U. Popat, J. Tarrand, R. Champlin, 2013, The Journal of antimicrobial chemotherapy.

Review Article Management of respiratory viral infections in hematopoietic cell transplant recipients

R. Chemaly, S. Ghantoji, E. Ariza-Heredia, 2012 .

Characteristics and Outcome of Cytomegalovirus (CMV) Infections in 95 Cord Blood Transplant (CBT) Recipients: The MD Anderson Experience

E. Shpall, K. Rezvani, R. Chemaly, 2014 .

Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis

Hannah C. Beird, N. Ajami, J. Petrosino, 2015, PloS one.

The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients

E. Shpall, K. Rezvani, R. Chemaly, 2018, The Journal of infectious diseases.

Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms

J. Fleming, R. Chemaly, S. Ghantoji, 2017, BMC Infectious Diseases.

Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.

C. Arias, B. Hanson, R. Chemaly, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes associated with pharmacotherapy in overactive bladder

R. Balkrishnan, M. Bhosle, S. Ghantoji, 2005, Expert review of pharmacoeconomics & outcomes research.

The Economic and Clinical Burden of Respiratory Viral Infections in Hematopoietic Cell Transplant (HCT) Recipients: A Cost Comparison Study Across 19 Major Cancer Centers in the U. S

D. Lairson, R. Chemaly, S. Ghantoji, 2016 .

Clinical and Economic Burden of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients: The MD Anderson Experience

D. Lairson, S. Karanth, R. Chemaly, 2017, Open Forum Infectious Diseases.

Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.

V. Tam, D. Kontoyiannis, R. Chemaly, 2016, The Journal of antimicrobial chemotherapy.

A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.

V. Tam, K. Garey, H. Dupont, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients

R. Chemaly, S. Ghantoji, E. Ariza-Heredia, 2018, Open Forum Infectious Diseases.

Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

R. Chemaly, S. Ghantoji, S. Aitken, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical and economic burden of pre‐emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients

R. Champlin, R. Chemaly, G. Rondón, 2020, Journal of medical virology.

Influenza Vaccination in Patients With Cancer: Factors Associated With Vaccination Practices for Patients and Their Household Members

R. Chemaly, L. Nesher, S. Ghantoji, 2015, Infection Control & Hospital Epidemiology.

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection

R. Chemaly, S. Ghantoji, D. Shah, 2018, The Journal of antimicrobial chemotherapy.

Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013.

P. Piedra, R. Chemaly, S. Ghantoji, 2015, The Journal of infectious diseases.

Respiratory Syncytial Virus Infections in Children With Cancer

R. Champlin, R. Chemaly, S. Ghantoji, 2014, Journal of pediatric hematology/oncology.

The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment

J. Stachowiak, R. Chemaly, S. Ghantoji, 2014, Therapeutic advances in infectious disease.

High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection.

K. Garey, V. Arora, H. Dupont, 2011, The Journal of hospital infection.

An Open Label, Block-Randomized, Ribavirin Efficacy Trial for Management of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients: Clinical and Economic Implications

P. Piedra, R. Chemaly, C. Hosing, 2016 .

Novel intervention for eliminating VRE from the environment.

R. Chemaly, S. Ghantoji, M. Stibich, 2011, Archives of Internal Medicine.

Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection.

K. Garey, H. Dupont, P. Rowan, 2011, The Journal of hospital infection.